The Effect on Prognosis of Postoperative CA 19-9 Level in Patients With Pancreatic Cancer

被引：1
|
作者：
Kilickap, Saadettin [1 ]
Arslan, Cagatay [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2010年 / 33卷 / 03期
关键词：
RECURRENCE; ADENOCARCINOMA; SURVIVAL;
D O I：
10.1097/COC.0b013e31819fe1ff
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [1] CA 19-9 serum course and prognosis of pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1996, 20 (03) : 155 - 161
  • [2] Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer: Second highest level of CA 19-9 in literature
    Kizilarslanoglu, Muhammet Cemal
    Civelek, Ramazan
    Kilic, Mustafa Kemal
    Kerem, Mustafa
    Gunaydin, Yusuf
    Ulger, Sukran
    JOURNAL OF BUON, 2014, 19 (02): : 583 - 584
  • [3] Serum CA 19-9 level as a surrogate marker for prognosis in locally advanced pancreatic cancer (LAPC)
    Fogelman, D. R.
    Pathak, P.
    Qiao, W.
    Chadha, R.
    Jhamb, J.
    Melisi, D.
    Wolff, R. A.
    Abbruzzese, J. L.
    Javle, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Shojiro Hata
    Yoshihiro Sakamoto
    Yusuke Yamamoto
    Satoshi Nara
    Minoru Esaki
    Kazuaki Shimada
    Tomoo Kosuge
    Annals of Surgical Oncology, 2012, 19 : 636 - 641
  • [5] Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Hata, Shojiro
    Sakamoto, Yoshihiro
    Yamamoto, Yusuke
    Nara, Satoshi
    Esaki, Minoru
    Shimada, Kazuaki
    Kosuge, Tomoo
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) : 636 - 641
  • [6] CA 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer
    Molina, Victor
    Visa, Laura
    Conill, Carles
    Navarro, Salvador
    Escudero, Jose M.
    Auge, Jose M.
    Filella, Xavier
    Lopez-Boado, Miguel A.
    Ferrer, Joana
    Fernandez-Cruz, Laureano
    Molina, Rafael
    TUMOR BIOLOGY, 2012, 33 (03) : 799 - 807
  • [7] Role of CA 19-9 As a Prognosis Factor Before and After Pancreatic Cancer Treatment
    Kim, Youn Joo
    Park, Joo Kyung
    Yang, Ki Young
    Seo, Jeong Kyun
    Kim, Yong-Tae
    Yoon, Yong Bum
    GASTROENTEROLOGY, 2009, 136 (05) : A390 - A390
  • [8] Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer and chronic renal failure: Second highest level of CA 19-9 in the literature
    Aytekin, Aydin
    Sahin, Suleyman
    Hacioglu, Muhammet Bekir
    Karatas, Fatih
    Ince, Menre
    JOURNAL OF BUON, 2015, 20 (04): : 1169 - 1170
  • [9] CA 19-9: Not a magic marker for pancreatic cancer
    Daram, Sumanth R.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (03) : 205 - 205
  • [10] Exploiting the relevance of CA 19-9 in pancreatic cancer
    Salleh, Syaza
    Thyagarajan, Anita
    Sahu, Ravi P.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
12345